angiotensin ii has been researched along with ginsenosides in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, K; Kakizaki, A; Kashimoto, T; Kudo, K; Miyate, Y; Tachikawa, E; Takahashi, E | 1 |
| Chen, YJ; Huang, QF; Li, JD | 1 |
| Qu, SC; Sui, DY; Wang, T; Xu, HL; Yu, XF | 1 |
| Han, B; Qu, S; Shi, Y; Sui, D; Yu, X | 1 |
| Dong, J; Gao, Z; Huang, Y; Lau, CW; Liu, P; Ng, CF; Tang, J; Wang, Y; Zhou, D | 1 |
| Azonpi, A; Bahem, R; Caballero-George, C; Hoffmann, A; Vanderheyden, P | 1 |
| He, C; Li, P; Su, H; Tian, K; Wan, JB; Zhang, XJ | 1 |
| Fan, JM; Mao, N; Shi, XL; Tan, RZ; Wang, L; Wang, SQ; Wei, C | 1 |
| Cui, X; Hong, L; Jin, HH; Li, X; Liu, LP; Liu, X; Zhang, B; Zhang, QG | 1 |
| Du, W; Li, X; Xiao, X; Zhang, F; Zhang, S; Zhang, Y; Zhu, M | 1 |
| Hu, X; Liu, S; Sun, Z; Tan, X; Wang, H; Wang, R; Zhang, B | 1 |
| Cui, X; Li, X; Liu, LP; Piao, HR; Xing, DL; Zhang, QG; Zhao, YQ; Zhou, S | 1 |
| Chen, C; Feng, J; Guo, Y; Qin, Q; Ren, B; Yang, N | 1 |
| Byun, JK; Jeong, JH; Kim, DJ; Kim, HC; Ko, SK; Lee, Y; Lei, XG; Nabeshima, T; Nah, SY; Nguyen, BT; Sharma, N; Shin, EJ | 1 |
14 other study(ies) available for angiotensin ii and ginsenosides
| Article | Year |
|---|---|
Effects of ginseng saponins on responses induced by various receptor stimuli.
Topics: Adrenal Glands; Angiotensin II; Animals; Bradykinin; Catecholamines; Cattle; Central Nervous System Agents; Chromaffin Cells; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Ginsenosides; Guinea Pigs; Histamine; Ileum; In Vitro Techniques; Male; Muscarine; Muscarinic Agonists; Muscle Contraction; Neurotensin; Nicotine; Nicotinic Agonists; Panax; Plants, Medicinal; Receptors, Cell Surface; Saponins | 1999 |
[Effects of Panax notoginseng saponins on rat cardiomyocytes apoptosis induced by angiotengin II in vitro].
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; Calcium; Cell Survival; Cells, Cultured; Female; Ginsenosides; Male; Myocytes, Cardiac; Panax; Plants, Medicinal; Rats; Rats, Wistar | 2005 |
Ginsenoside Rb3 inhibits angiotensin II-induced vascular smooth muscle cells proliferation.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Cell Cycle; Cell Proliferation; Cells, Cultured; DNA; Drug Antagonism; Ginsenosides; Male; Muscle, Smooth, Vascular; Panax; Plant Extracts; Rats; Rats, Sprague-Dawley | 2010 |
Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats.
Topics: Angiotensin II; Animals; Antioxidants; Cardiotonic Agents; China; Creatine Kinase; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelins; Ginsenosides; Heart Ventricles; L-Lactate Dehydrogenase; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Panax; Phytotherapy; Plant Extracts; Random Allocation; Rats; Rats, Sprague-Dawley; Single-Blind Method; Superoxide Dismutase | 2011 |
Ginsenoside Rb3 attenuates oxidative stress and preserves endothelial function in renal arteries from hypertensive rats.
Topics: Adult; Aged; Angiotensin II; Animals; Dose-Response Relationship, Drug; Endothelium, Vascular; Ginsenosides; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Middle Aged; NADPH Oxidases; Nitric Oxide; Oxidative Stress; Panax; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Renal Artery; Vasoconstriction | 2014 |
Modulation of Calcium Signaling of Angiotensin AT1, Endothelin ETA, and ETB Receptors by Silibinin, Quercetin, Crocin, Diallyl Sulfides, and Ginsenoside Rb1.
Topics: Allyl Compounds; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensins; Animals; Calcium Signaling; Carotenoids; CHO Cells; Cricetinae; Cricetulus; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Female; Ginsenosides; Humans; Quercetin; Receptors, Angiotensin; Receptors, Endothelin; Silybin; Silymarin; Sulfides | 2015 |
Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Apolipoproteins E; Apoptosis; Disease Models, Animal; Enzyme Activators; Extracellular Matrix; Ginsenosides; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Severity of Illness Index; Signal Transduction; Vascular Remodeling | 2015 |
Ginsenoside Rg1 inhibits angiotensin II-induced podocyte autophagy via AMPK/mTOR/PI3K pathway.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Antioxidants; Apoptosis; Autophagy; Cell Line; Down-Regulation; Ginsenosides; Mice; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Podocytes; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases | 2016 |
Ginsenoside Re prevents angiotensin II-induced gap-junction remodeling by activation of PPARγ in isolated beating rat atria.
Topics: Angiotensin II; Anilides; Animals; Blotting, Western; Connexin 43; Connexins; Dose-Response Relationship, Drug; Down-Regulation; Female; Gap Junction alpha-5 Protein; Gap Junctions; Ginsenosides; Heart Atria; Male; Matrix Metalloproteinase 2; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2017 |
Research on Q-markers of Qiliqiangxin capsule for chronic heart failure treatment based on pharmacokinetics and pharmacodynamics association.
Topics: Aconitine; Angiotensin II; Animals; Benzofurans; Biomarkers; Chromatography, High Pressure Liquid; Chronic Disease; Drugs, Chinese Herbal; Ginsenosides; Heart Failure; Isoflavones; Male; Medicine, Chinese Traditional; Quality Control; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2018 |
Effects of a dammarane-type saponin, ginsenoside Rd, in nicotine-induced vascular endothelial injury.
Topics: Angiotensin II; Animals; Aorta; Dammaranes; Endothelium, Vascular; Ginsenosides; Human Umbilical Vein Endothelial Cells; Humans; Male; Myeloid Differentiation Factor 88; NF-kappa B; Nicotine; Nitric Oxide; Nitric Oxide Synthase Type III; Phenylephrine; Platelet Aggregation; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Toll-Like Receptor 4; Triterpenes; Vasoconstriction | 2020 |
The novel ginsenoside AD2 prevents angiotensin II-induced connexin 40 and connexin 43 dysregulation by activating AMP kinase signaling in perfused beating rat atria.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Connexin 43; Connexins; Down-Regulation; Fibrosis; Gap Junction alpha-5 Protein; Gap Junctions; Ginsenosides; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor AP-1; Transforming Growth Factor beta1; Up-Regulation | 2021 |
Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1/NF-κB pathway.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta; Cells, Cultured; Disease Models, Animal; Fibrosis; Ginsenosides; Humans; Hypertrophy; Immunomodulation; Inflammasomes; Myocardium; Myocytes, Cardiac; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats; Signal Transduction; Sirtuin 1 | 2021 |
Ginsenoside Re attenuates memory impairments in aged Klotho deficient mice via interactive modulations of angiotensin II AT1 receptor, Nrf2 and GPx-1 gene.
Topics: Angiotensin II; Animals; Antioxidants; Ginsenosides; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Klotho Proteins; Losartan; Memory Disorders; Mice; Mice, Knockout; NF-E2-Related Factor 2; Reactive Oxygen Species; Receptor, Angiotensin, Type 1 | 2022 |